Global Tacrolimus Capsules 麻豆原创 Research Report 2023

Publication ID:

PB503237683

Publication Date:

March 13, 2023

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Healthcare [2]

Pharma & Healthcare [3]

Description:

It is used to keep the body from harming the organ after an organ transplant.听
Highlights
The global Tacrolimus Capsules market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for Tacrolimus Capsules is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Tacrolimus Capsules is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global manufacturers of Tacrolimus Capsules include Accord Healthcare, Bionpharma, Major Pharmaceuticals, Sandoz, Astellas Pharma, Lannett, Mylan, Hisun Pharm and Zhejiang Hongsheng Pharm, etc. in 2022, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Tacrolimus Capsules, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Tacrolimus Capsules.
The Tacrolimus Capsules market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Tacrolimus Capsules market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Tacrolimus Capsules manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
Accord Healthcare
Bionpharma
Major Pharmaceuticals
Sandoz
Astellas Pharma
Lannett
Mylan
Hisun Pharm
Zhejiang Hongsheng Pharm
Huadong Medicine
Segment by Type
0.5mg/pill
1mg/pill
5mg/pill
Segment by Application
Hospital
Special Clinic
Recovery Center
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Tacrolimus Capsules manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Tacrolimus Capsules in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Tacrolimus Capsules 麻豆原创 Overview
1.1 Product Overview and Scope of Tacrolimus Capsules
1.2 Tacrolimus Capsules Segment by Type
1.2.1 Global Tacrolimus Capsules 麻豆原创 Value Comparison by Type (2023-2029)
1.2.2 0.5mg/pill
1.2.3 1mg/pill
1.2.4 5mg/pill
1.3 Tacrolimus Capsules Segment by Application
1.3.1 Global Tacrolimus Capsules 麻豆原创 Value by Application: (2023-2029)
1.3.2 Hospital
1.3.3 Special Clinic
1.3.4 Recovery Center
1.4 Global Tacrolimus Capsules 麻豆原创 Size Estimates and Forecasts
1.4.1 Global Tacrolimus Capsules Revenue 2018-2029
1.4.2 Global Tacrolimus Capsules Sales 2018-2029
1.4.3 Global Tacrolimus Capsules 麻豆原创 Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Tacrolimus Capsules 麻豆原创 Competition by Manufacturers
2.1 Global Tacrolimus Capsules Sales 麻豆原创 Share by Manufacturers (2018-2023)
2.2 Global Tacrolimus Capsules Revenue 麻豆原创 Share by Manufacturers (2018-2023)
2.3 Global Tacrolimus Capsules Average Price by Manufacturers (2018-2023)
2.4 Global Tacrolimus Capsules Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Tacrolimus Capsules, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Tacrolimus Capsules, Product Type & Application
2.7 Tacrolimus Capsules 麻豆原创 Competitive Situation and Trends
2.7.1 Tacrolimus Capsules 麻豆原创 Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Tacrolimus Capsules Players 麻豆原创 Share by Revenue
2.7.3 Global Tacrolimus Capsules 麻豆原创 Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Tacrolimus Capsules Retrospective 麻豆原创 Scenario by Region
3.1 Global Tacrolimus Capsules 麻豆原创 Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Tacrolimus Capsules Global Tacrolimus Capsules Sales by Region: 2018-2029
3.2.1 Global Tacrolimus Capsules Sales by Region: 2018-2023
3.2.2 Global Tacrolimus Capsules Sales by Region: 2024-2029
3.3 Global Tacrolimus Capsules Global Tacrolimus Capsules Revenue by Region: 2018-2029
3.3.1 Global Tacrolimus Capsules Revenue by Region: 2018-2023
3.3.2 Global Tacrolimus Capsules Revenue by Region: 2024-2029
3.4 North America Tacrolimus Capsules 麻豆原创 Facts & Figures by Country
3.4.1 North America Tacrolimus Capsules 麻豆原创 Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Tacrolimus Capsules Sales by Country (2018-2029)
3.4.3 North America Tacrolimus Capsules Revenue by Country (2018-2029)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Tacrolimus Capsules 麻豆原创 Facts & Figures by Country
3.5.1 Europe Tacrolimus Capsules 麻豆原创 Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Tacrolimus Capsules Sales by Country (2018-2029)
3.5.3 Europe Tacrolimus Capsules Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Tacrolimus Capsules 麻豆原创 Facts & Figures by Country
3.6.1 Asia Pacific Tacrolimus Capsules 麻豆原创 Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Tacrolimus Capsules Sales by Country (2018-2029)
3.6.3 Asia Pacific Tacrolimus Capsules Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Tacrolimus Capsules 麻豆原创 Facts & Figures by Country
3.7.1 Latin America Tacrolimus Capsules 麻豆原创 Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Tacrolimus Capsules Sales by Country (2018-2029)
3.7.3 Latin America Tacrolimus Capsules Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Tacrolimus Capsules 麻豆原创 Facts & Figures by Country
3.8.1 Middle East and Africa Tacrolimus Capsules 麻豆原创 Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Tacrolimus Capsules Sales by Country (2018-2029)
3.8.3 Middle East and Africa Tacrolimus Capsules Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Tacrolimus Capsules Sales by Type (2018-2029)
4.1.1 Global Tacrolimus Capsules Sales by Type (2018-2023)
4.1.2 Global Tacrolimus Capsules Sales by Type (2024-2029)
4.1.3 Global Tacrolimus Capsules Sales 麻豆原创 Share by Type (2018-2029)
4.2 Global Tacrolimus Capsules Revenue by Type (2018-2029)
4.2.1 Global Tacrolimus Capsules Revenue by Type (2018-2023)
4.2.2 Global Tacrolimus Capsules Revenue by Type (2024-2029)
4.2.3 Global Tacrolimus Capsules Revenue 麻豆原创 Share by Type (2018-2029)
4.3 Global Tacrolimus Capsules Price by Type (2018-2029)
5 Segment by Application
5.1 Global Tacrolimus Capsules Sales by Application (2018-2029)
5.1.1 Global Tacrolimus Capsules Sales by Application (2018-2023)
5.1.2 Global Tacrolimus Capsules Sales by Application (2024-2029)
5.1.3 Global Tacrolimus Capsules Sales 麻豆原创 Share by Application (2018-2029)
5.2 Global Tacrolimus Capsules Revenue by Application (2018-2029)
5.2.1 Global Tacrolimus Capsules Revenue by Application (2018-2023)
5.2.2 Global Tacrolimus Capsules Revenue by Application (2024-2029)
5.2.3 Global Tacrolimus Capsules Revenue 麻豆原创 Share by Application (2018-2029)
5.3 Global Tacrolimus Capsules Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Accord Healthcare
6.1.1 Accord Healthcare Corporation Information
6.1.2 Accord Healthcare Description and Business Overview
6.1.3 Accord Healthcare Tacrolimus Capsules Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Accord Healthcare Tacrolimus Capsules Product Portfolio
6.1.5 Accord Healthcare Recent Developments/Updates
6.2 Bionpharma
6.2.1 Bionpharma Corporation Information
6.2.2 Bionpharma Description and Business Overview
6.2.3 Bionpharma Tacrolimus Capsules Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Bionpharma Tacrolimus Capsules Product Portfolio
6.2.5 Bionpharma Recent Developments/Updates
6.3 Major Pharmaceuticals
6.3.1 Major Pharmaceuticals Corporation Information
6.3.2 Major Pharmaceuticals Description and Business Overview
6.3.3 Major Pharmaceuticals Tacrolimus Capsules Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Major Pharmaceuticals Tacrolimus Capsules Product Portfolio
6.3.5 Major Pharmaceuticals Recent Developments/Updates
6.4 Sandoz
6.4.1 Sandoz Corporation Information
6.4.2 Sandoz Description and Business Overview
6.4.3 Sandoz Tacrolimus Capsules Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Sandoz Tacrolimus Capsules Product Portfolio
6.4.5 Sandoz Recent Developments/Updates
6.5 Astellas Pharma
6.5.1 Astellas Pharma Corporation Information
6.5.2 Astellas Pharma Description and Business Overview
6.5.3 Astellas Pharma Tacrolimus Capsules Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Astellas Pharma Tacrolimus Capsules Product Portfolio
6.5.5 Astellas Pharma Recent Developments/Updates
6.6 Lannett
6.6.1 Lannett Corporation Information
6.6.2 Lannett Description and Business Overview
6.6.3 Lannett Tacrolimus Capsules Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Lannett Tacrolimus Capsules Product Portfolio
6.6.5 Lannett Recent Developments/Updates
6.7 Mylan
6.6.1 Mylan Corporation Information
6.6.2 Mylan Description and Business Overview
6.6.3 Mylan Tacrolimus Capsules Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Mylan Tacrolimus Capsules Product Portfolio
6.7.5 Mylan Recent Developments/Updates
6.8 Hisun Pharm
6.8.1 Hisun Pharm Corporation Information
6.8.2 Hisun Pharm Description and Business Overview
6.8.3 Hisun Pharm Tacrolimus Capsules Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Hisun Pharm Tacrolimus Capsules Product Portfolio
6.8.5 Hisun Pharm Recent Developments/Updates
6.9 Zhejiang Hongsheng Pharm
6.9.1 Zhejiang Hongsheng Pharm Corporation Information
6.9.2 Zhejiang Hongsheng Pharm Description and Business Overview
6.9.3 Zhejiang Hongsheng Pharm Tacrolimus Capsules Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Zhejiang Hongsheng Pharm Tacrolimus Capsules Product Portfolio
6.9.5 Zhejiang Hongsheng Pharm Recent Developments/Updates
6.10 Huadong Medicine
6.10.1 Huadong Medicine Corporation Information
6.10.2 Huadong Medicine Description and Business Overview
6.10.3 Huadong Medicine Tacrolimus Capsules Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Huadong Medicine Tacrolimus Capsules Product Portfolio
6.10.5 Huadong Medicine Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Tacrolimus Capsules Industry Chain Analysis
7.2 Tacrolimus Capsules Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Tacrolimus Capsules Production Mode & Process
7.4 Tacrolimus Capsules Sales and 麻豆原创ing
7.4.1 Tacrolimus Capsules Sales Channels
7.4.2 Tacrolimus Capsules Distributors
7.5 Tacrolimus Capsules Customers
8 Tacrolimus Capsules 麻豆原创 Dynamics
8.1 Tacrolimus Capsules Industry Trends
8.2 Tacrolimus Capsules 麻豆原创 Drivers
8.3 Tacrolimus Capsules 麻豆原创 Challenges
8.4 Tacrolimus Capsules 麻豆原创 Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 麻豆原创 Size Estimation
10.1.3 麻豆原创 Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Companies Mentioned:

Accord Healthcare
Bionpharma
Major Pharmaceuticals
Sandoz
Astellas Pharma
Lannett
Mylan
Hisun Pharm
Zhejiang Hongsheng Pharm
Huadong Medicine

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.